Vaccine spat heats up as AstraZeneca confirms plans for EU talks

Spat between AstraZeneca and the EU raises concerns about vaccine nationalism, as nations jockey for limited supplies. The European Union’s dispute with AstraZeneca intensified Wednesday with the Anglo-Swedish drugmaker denying the EU’s assertion that it had pulled out of talks on COVID-19